Data from Suppression of Androgen-Independent Prostate Cancer Cell Aggressiveness by FTY720: Validating Runx2 as a Potential Antimetastatic Drug Screening Platform
Authors:
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)